Effect of genetic variation of IL-13 on airway remodeling in bronchial asthma

Allergology International

Volumn 60, Issue 3, 2011, Pages 291-298

  Nagashima, Hiromi ^a   Nakamura, Yutaka ^a   Kanno, Hiroyuki ^b   Sawai, Takashi ^b   Inoue, Hiroshi ^c   Yamauchi, Kohei ^a  

^a Allergy and Rheumatology   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Bronchial asthma; Bronchial biopsy; Bronchial lavage fluid; Il 13; Polymorphisms

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYALURONIC ACID; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 23; METHACHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 2; RNA;

ADULT; AIRWAY REMODELING; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CONTROLLED STUDY; FEMALE; FIBEROPTIC BRONCHOSCOPY; FOLLOW UP; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; JAPAN; LUNG FUNCTION TEST; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESPIRATORY TRACT INFLAMMATION; SMOKING HABIT; SPIROMETRY;

EID: 80052671271     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-OA-0259     Document Type: Article

References (30)

1. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
2. Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 1998;53:21-7.
3. Huang J, Olivenstein R, Taha R, Hamid Q, Ludwig M. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 1999;160: 725-9.
4. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001;107:1034-8.
5. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1:520-4.
6. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
7. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003;111:291-7.
8. Belperio JA, Dy M, Burdick MD et al. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2002;27:419-27.
9. van der Pouw Kraan TC, Küçükaycan M, Bakker AM et al. Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun 2002;3:436-9.
10. Hoffjan S, Ostrovnaja I, Nicolae D et al. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J Allergy Clin Immunol 2004;113:511-8.
11. Cameron L, Webster RB, Strempel JM et al. Th2 cellselective enhancement of human IL13 transcription by IL 13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol 2006;177:8633-42.
12. Maier LM, Howson JM, Walker N et al. Association of IL 13 with total IgE: evidence against an inverse association of atopy and diabetes. J Allergy Clin Immunol 2006;117: 1306-13.
13. Heinzmann A, Mao XQ, Akaiwa M et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000;9:549-59.
14. Arima K, Umeshita-Suyama R, Sakata Y et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002;109:980-7.
15. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application. Chest 1981; 80:600-6.
16. Nakamura Y, Hoshino M, Sim JJ, Ishii K, Hosaka K, Sakamoto T. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 1998;53:835-41.
17. Takahashi S, Nakamura Y, Nishijima T, Sakurai S, Inoue H. Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome. Respir Med 2005;99:1125-31.
18. Vignola AM, Chanez P, Chiappara G et al. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997;156:591-9.
19. Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinsas-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998;102:783-8.
20. Hoshino M, Nakamura Y, Sim JJ et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 1998;28: 568-77.
21. Hoshino M, Aoike N, Takahashi M, Nakamura Y, Nakagawa T. Increased immunoreactivity of stromal cellderived factor-1 and angiogenesis in asthma. Eur Respir J 2003;21:804-9.
22. Liu X, Nickel R, Beyer K et al. An IL-13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 2000;106:167-70.
23. Graves PE, Kabesch M, Halonen M et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000;105: 506-13.
24. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005; 115:747-54.
25. Wakashin H, Hirose K, Maezawa Y et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008;178: 1023-32.
26. Minshall E, Chakir J, Laviolette M et al. IL-11 expression is increased is severe asthma: association with epithelial cells and eosinophils. J Allergy Clin Immunol 2000;105: 232-8.
27. Chen Q, Rabach L, Noble P et al. IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2005;174:2305-13.
28. Woolley KL, Adelroth E, Woolley MJ, Ellis R, Jordana M, O'Byrne PM. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma. Am J Respir Crit Care Med 1995;151:1915-24.
29. Busse WW, Pedersen S, Pauwels RA et al. The Inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2008;121:1167-74.
30. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-63.